Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

214
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
214
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

133
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
133
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

56
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
56
Cross-reactivity00:42

Cross-reactivity

31.4K
Overview
31.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Global 30-Day Morbidity and Mortality of Primary Bariatric Surgery Combined with Another Procedure: The BLEND Study.

Obesity surgery·2026
Same author

Life-Threatening Gastrointestinal Bleeding Revealing a Rare Coexistence of Ampullary Ganglioneuroma and Pancreatic Neuroendocrine Tumor: A Case Report.

Diagnostics (Basel, Switzerland)·2026
Same author

An Agentic LLM Framework for Autonomous Surgical Continuum Monitoring: ReAct-Driven Tool-Use Agents for Presurgical, Intraoperative, and Postsurgical Cardiopulmonary Care.

Bioengineering (Basel, Switzerland)·2026
Same author

Vasa Vasorum-A Silent Enemy After EVAR: A Case Report and Review of the Literature.

Clinics and practice·2026
Same author

Inequalities in Access to and Outcomes of Cardiac Surgery Among Patients with Mental Health Disorders.

Medical sciences (Basel, Switzerland)·2026
Same author

Comprehensive Management of Delayed Pediatric Nail Puncture Injury Complicated by Severe Soft-Tissue Infection: The Adjunctive Role of Negative Pressure Wound Therapy

Chirurgia (Bucharest, Romania : 1990)·2026

Related Experiment Video

Updated: Aug 6, 2025

Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

8.0K

Cold Reactive Proteins in Cardiovascular Surgery.

Ioannis Panagiotopoulos1, Francesk Mulita2, Georgios-Ioannis Verras2

  • 1Cardiac Surgery Department, University Hospital of Patras, Patras, Greece.

Materia Socio-Medica
|March 20, 2023
PubMed
Summary

Maintaining systemic temperature above the cold-reactive protein threshold during cardiopulmonary bypass is crucial for successful cardiovascular surgery, as demonstrated in a patient case.

Keywords:
Cold AgglutininsCold reactive proteinsCryofibrinogenCryoglobins

More Related Videos

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
10:01

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

10.9K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.4K

Related Experiment Videos

Last Updated: Aug 6, 2025

Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

8.0K
Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
10:01

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

10.9K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.4K

Area of Science:

  • Cardiovascular Surgery
  • Immunology
  • Protein Chemistry

Background:

  • Four types of cold-reactive proteins exist: Cryoglobins, Cold Agglutinins, Donath-Landsteiner antibodies, and Cryofibrinogen.
  • These proteins can pose risks during procedures requiring altered body temperatures.

Observation:

  • A 57-year-old male with coronary artery disease, diabetes, and a history of smoking underwent coronary artery bypass grafting.
  • The patient had no history of relevant autoimmune or infectious conditions.
  • The surgery involved median sternotomy and cardiopulmonary bypass.

Findings:

  • The patient experienced a smooth postoperative recovery without neurological, cardiac, or renal complications.
  • Systemic temperature management during cardiopulmonary bypass was critical for preventing complications.

Implications:

  • This case highlights the importance of understanding and managing cold-reactive proteins in cardiovascular surgery.
  • Maintaining adequate systemic temperature during cardiopulmonary bypass is essential for patient safety and optimal outcomes.